The Effect of Pharmacist Intervention on Blood Pressure Control
AFenPA
Pharmacist Intervention Effect on the Medication Adherence and Blood Pressure Control in Treated Patients
1 other identifier
interventional
140
1 country
2
Brief Summary
The purpose of the study is to test if a Pharmacist Intervention Program with home blood pressure monitoring (HBPM) improves or controls pharmacological adherence and blood pressure levels in hypertensive patients under pharmacological treatment, compared to those who receive usual care in a community pharmacy setting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable hypertension
Started Feb 2010
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2010
CompletedFirst Submitted
Initial submission to the registry
October 29, 2010
CompletedFirst Posted
Study publicly available on registry
November 3, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2011
CompletedMay 6, 2016
February 1, 2010
1.6 years
October 29, 2010
May 5, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
blood pressure control
Percentage of patients with controlled hypertension
At 6 months
Secondary Outcomes (1)
Adherence
At 6 months
Study Arms (2)
Intervention
EXPERIMENTALThe intervention group receive an pharmacist intervention (health education, Home Blood Pressure Monitoring and Referral to physician as needed) This group will be followed for 6 months
Control
NO INTERVENTIONThe control group receive usual care in the community pharmacy
Interventions
Health education (on hypertension, smoking, healthy diet, obesity, physical inactivity and adherence to antihypertensive medications and home blood pressure monitoring) . The patient will be referred to physician when needed. The patient will be followed up during 6 months.
Eligibility Criteria
You may qualify if:
- Patients of both genders between the ages of 18 and 80 years, who access the pharmacy to fill their own prescription for hypertension.
You may not qualify if:
- Patient living with an other Hypertensive patient treated with the same medications
- Pregnant women
- Hypertensive patients with levels of systolic/diastolic blood pressure ≥ 180mmHg/110mmHg
- Patient with secondary hypertension, kidney or liver failure
- Patients already included in a care program for hypertensive patients
- Patients with a new treatment for hypertension (less than 1 month)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Community Pharmacies
Granada, Andalusia, 18000, Spain
Community Pharmacies
Jaén, Andalusia, 23000, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Maria Jose Faus, PhD
Universidad de Granada
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
October 29, 2010
First Posted
November 3, 2010
Study Start
February 1, 2010
Primary Completion
September 1, 2011
Study Completion
September 1, 2011
Last Updated
May 6, 2016
Record last verified: 2010-02